SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001125282-04-002310
Filing Date
2004-05-17
Accepted
2004-05-17 17:11:57
Documents
1
Group Members
DELPHI BIO INVESTMENTS VI, L.P.DELPHI MANAGEMENT PARTNERS VI, L.L.C.DELPHI VENTURES VI, L.P.FELIX J. BAKERJ.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN) II, L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS A, L

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D b332053_sch13d.txt SC 13D 106307
  Complete submission text file 0001125282-04-002310.txt   108935
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Subject) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-61317 | Film No.: 04813481
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020
Business Address J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 2128993400
JP MORGAN PARTNERS BHCA LP (Filed by) CIK: 0001106607 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231